Business Description
Rewalk Robotics Ltd
NAICS : 339112
SIC : 3841
ISIN : IL0011331076
Description
Rewalk Robotics Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord injury. It operates through markets in the United States and Europe with some lesser sales in Asia, the Middle East and South America.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.76 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -4.17 | |||||
| Beneish M-Score | 12.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.9 | |||||
| 3-Year EBITDA Growth Rate | 21.2 | |||||
| 3-Year EPS without NRI Growth Rate | 23.2 | |||||
| 3-Year FCF Growth Rate | 24.4 | |||||
| 3-Year Book Growth Rate | -3.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.11 | |||||
| 9-Day RSI | 48.83 | |||||
| 14-Day RSI | 46.09 | |||||
| 6-1 Month Momentum % | -1.6 | |||||
| 12-1 Month Momentum % | 26.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.33 | |||||
| Quick Ratio | 2.85 | |||||
| Cash Ratio | 2.38 | |||||
| Days Inventory | 160.66 | |||||
| Days Sales Outstanding | 47.38 | |||||
| Days Payable | 134.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.4 | |||||
| Shareholder Yield % | 0.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.14 | |||||
| Operating Margin % | -170.44 | |||||
| Net Margin % | -159.76 | |||||
| FCF Margin % | -149.18 | |||||
| ROE % | -38.3 | |||||
| ROA % | -32.41 | |||||
| ROIC % | -152.63 | |||||
| ROC (Joel Greenblatt) % | -853.77 | |||||
| ROCE % | -39 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.01 | |||||
| PB Ratio | 0.9 | |||||
| Price-to-Tangible-Book | 1.58 | |||||
| EV-to-EBIT | -0.63 | |||||
| EV-to-EBITDA | -0.68 | |||||
| EV-to-Revenue | 1.07 | |||||
| EV-to-Forward-Revenue | 0.43 | |||||
| EV-to-FCF | -0.71 | |||||
| Price-to-Net-Current-Asset-Value | 1.86 | |||||
| Price-to-Net-Cash | 3.66 | |||||
| Earnings Yield (Greenblatt) % | -158.73 | |||||
| FCF Yield % | -49.33 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers